Adial Pharmaceuticals, Inc. Cash
Adial Pharmaceuticals, Inc. (ADIL) had Cash of $11.00 million as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2023-05-12
- 2023-03-31: Cash $11.00M.
- 2022-12-31: Cash $64.20K.
- 2019-12-31: Cash $400.00K.
- 2019-09-30: Cash $8.30M.
| Period end | Cash |
|---|---|
| 2023-03-31 | $11.00M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $64.20K 10-K · filed 2023-03-30 |
| 2019-12-31 | $400.00K 10-K · filed 2020-03-20 |
| 2019-09-30 | $8.30M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $10.00M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $11.10M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $3.40M 10-K · filed 2020-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |